Insmed (INSM) PT Raised to $67 at TD Cowen
TD Cowen analyst Ritu Baral raised the price target on Insmed (NASDAQ: INSM) to $67.00 (from $45.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
